Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: June 2014

Chapter 43 - Traumatic brain injury

from Section 7 - Disease-specific neurorehabilitation systems


1. Brown AW, Elovic EP, Kothari S, et al. Congenital and acquired brain injury. 1. Epidemiology, pathophysiology, prognostication, innovative treatments, and prevention. Arch Phys Med Rehabil 2008; 89: S3–8.
2. Summers CR, Ivins B, Schwab KA. Traumatic brain injury in the United States: an epidemiologic overview. Mt Sinai J Med 2009; 76: 105–10.
3. Corrigan JD, Selassie AW, Orman JA. The epidemiology of traumatic brain injury. J Head Trauma Rehabil 2010; 25: 72–80.
4. DePalma RG, Burris DG, Champion HR, et al. Blast injuries. N Engl J Med 2005; 352: 1335–42.
5. Martin EM, Lu WC, Helmick K, et al. Traumatic brain injuries sustained in the Afghanistan and Iraq wars. Am J Nurs 2008; 108: 40–7.
6. Dardiotis E, Fountas KN, Dardioti M, et al. Genetic association studies in patients with traumatic brain injury. Neurosurg Focus 2010; 28: E9.
7. Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochem Res 2007; 32: 905–15.
8. Pelinka LE, Kroepfl A, Leixnering M, et al. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 2004; 21: 1553–61.
9. Berger RP, Adelson PD, Pierce MC, et al. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg 2005; 103: 61–8.
10. Wang KK, Posmantur R, Nath R, et al. Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J Biol Chem 1998; 273: 22490–7.
11. Svetlov SI, Larner SF, Kirk DR, et al. Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury. J Neurotrauma 2009; 26: 913–21.
12. Bazarian JJ, Blyth B, Cimpello L. Bench to bedside: evidence for brain injury after concussion–looking beyond the computed tomography scan. Acad Emerg Med 2006; 13: 199–214.
13. Dubroff JG, Newberg A. Neuroimaging of traumatic brain injury. Semin Neurol 2008; 28: 548–57.
14. De Coene B, Hajnal JV, Pennock JM, et al. MRI of the brain stem using fluid attenuated inversion recivery pulse sequences. Neuroradiology 1993; 35: 327–31.
15. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, Part 1. Am J Neuroradiol 2009; 30: 19–30.
16. Kou Z, Wu Z, Tong KA, et al. The role of advanced MR imaging findings as biomarkers of traumatic brain injury. J Head Trauma Rehabil 2010; 25: 267–82.
17. Tong KA, Ashwal S, Holshouser BA, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003; 227: 332–9.
18. Wu Z, Li S, Lei J, et al. Evaluation of traumatic subarachnoid hemorrhage using susceptibility-weighted imaging. Am J Neuroradiol 2010; 31: 1302–10.
19. Ptak T, Sheridan RL, Rhea JT, et al. Cerebral fractional anisotropy score in trauma patients: a new indicator of white matter injury after trauma. Am J Roentgenol 2003; 181: 1401–7.
20. Ross BD, Ernst T, Kreis R, et al. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging 1998; 8: 829–40.
21. Garnett MR, Blamire AM, Rajagopalan B, et al. Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: a magnetic resonance spectroscopy study. Brain 2000; 123: 1403–9.
22. Garnett MR, Corkill RG, Blamire AM, et al. Altered cellular metabolism following traumatic brain injury: a magnetic resonance spectroscopy study. J Neurotrauma 2001; 18: 231–40.
23. Ashwal S, Holshouser BA, Tong KA. Use of advanced neuroimaging techniques in the evaluation of pediatric traumatic brain injury. Dev Neurosci 2006; 28: 309–26.
24. Makoroff KL, Cecil KM, Care M, et al. Elevated lactate as an early marker of brain injury in inflicted traumatic brain injury. Pediatr Radiol 2005; 35: 668–76.
25. Alavi A, Mirot A, Newberg A, et al. Fluorine-18-FDG evaluation of crossed cerebellar diaschisis in head injury. J Nucl Med 1997; 38: 1717–20.
26. Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain 2005; 128: 2556–61.
27. Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999; 39: 19–52.
28. Ariza M, Matarin MD, Junque C, et al. Influence of angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury. J Neuropsychiatry Clin Neurosci 2006; 18: 39–44.
29. Martinez-Lucas P, Moreno-Cuesta J, Garcia-Olmo DC, et al. Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med 2005; 31: 1168–73.
30. Uzan M, Tanriverdi T, Baykara O, et al. Association between interleukin-1 beta (IL-1beta) gene polymorphism and outcome after head injury: an early report. Acta Neurochir 2005; 147: 715–20.
31. Hadjigeorgiou GM, Paterakis K, Dardiotis E, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology 2005; 65: 1077–82.
32. Chiaretti A, Antonelli A, Mastrangelo A, et al. Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma 2008; 25: 225–34.
33. Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury–a state-of-the-art review. J Rehabil Res Dev 2009; 46: 851–79.
34. Clifton GL, Miller ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001; 344: 556–63.
35. Clifton GL, Choi SC, Miller ER, et al. Intercenter variance in clinical trials of head trauma–experience of the National Acute Brain Injury Study: Hypothermia. J Neurosurg 2001; 95: 751–5.
36. Hutchison JS, Ward RE, Lacroix J, et al. Hypothermia therapy after traumatic brain injury in children. N Engl J Med 2008; 358: 2447–56.
37. Talving P, Lustenberger T, Kobayashi L, et al. Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Ann Surg 2010; 251: 1–4.
38. Stahel PF, Flierl MA. Erythropoietin in traumatic brain injury: the “golden bullet” on the horizon? Neurol India 2009; 57: 693–4.
39. Lu D, Mahmood A, Qu C, et al. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 2005; 22: 1011–17.
40. Mammis A, McIntosh TK, Maniker AH. Erythropoietin as a neuroprotective agent in traumatic brain injury: review. Surg Neurol 2009; 71: 527–31.
41. Wright DW, Kellermann AL, Hertzberg VS, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007; 49: 391–402.
42. Zafonte R, Friedewald WT, Lee SM, et al. The citicoline brain injury treatment (COBRIT) trial: design and methods. J Neurotrauma 2009; 26: 2207–16.
43. Dempsey RJ, Raghavendra Rao VL. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. J Neurosurg 2003; 98: 867–73.
44. Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002; 33: 2850–7.
45. Yurkewicz L, Weaver J, Bullock MR, et al. The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J Neurotrauma 2005; 22: 1428–43.
46. Maas AI, Murray G, Henney H, et al. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 2006; 5: 38–45.
47. Martin RT, Whyte J. The effects of methylphenidate on command following and yes/no communication in persons with severe disorders of consciousness: a meta-analysis of n-of-1 studies. Am J Phys Med Rehabil 2007; 86: 613–20.
48. Meythaler JM, Brunner RC, Johnson A, et al. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002; 17: 300–13.
49. Hughes S, Colantonio A, Santaguida PL, et al. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Inj 2005; 19: 1197–206.
50. Patrick PD, Blackman JA, Mabry JL, et al. Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol 2006; 21: 879–85.
51. Teitelman E. Off-label uses of modafinil. Am J Psychiatry 2001; 158: 1341.
52. Jha A, Weintraub A, Allshouse A, et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil 2008; 23: 52–63.
53. Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj 1988; 2: 273–90.
54. Plenger PM, Dixon CE, Castillo RM, et al. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 1996; 77: 536–40.
55. Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 2004; 83: 401–20.
56. Reid WM, Hamm RJ. Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury. J Neurotrauma 2008; 25: 248–56.
57. Ripley DL. Atomoxetine for individuals with traumatic brain injury. J Head Trauma Rehabil 2006; 21: 85–8.
58. Kraus MF, Maki PM. Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review. J Neuropsychiatry Clin Neurosci 1997; 9: 222–30.
59. Levin HS, Peters BH, Kalisky Z, et al. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Cent Nerv Syst Trauma 1986; 3: 333–42.
60. Cardenas DD, McLean A, Farrell-Roberts L, et al. Oral physostigmine and impaired memory in adults with brain injury. Brain Inj 1994; 8: 579–87.
61. Silver JM, Koumaras B, Chen M, et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology 2006; 67: 748–55.
62. Zhang L, Plotkin RC, Wang G, et al. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004; 85: 1050–5.
63. Riggio S, Wong M. Neurobehavioral sequelae of traumatic brain injury. Mt Sinai J Med 2009; 76: 163–72.
64. Lieberman SA, Oberoi AL, Gilkison CR, et al. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocr Metab 2001; 86: 2752–6.
65. Bondanelli M, De Marinis L, Ambrosio MR, et al. Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma 2004; 21: 685–96.
66. Schneider M, Schneider HJ, Stalla GK. Anterior pituitary hormone abnormalities following traumatic brain injury. J Neurotrauma 2005; 22: 937–46.
67. Ceballos R. Pituitary changes in head trauma (analysis of 102 consecutive cases of head injury). Ala J Med Sci 1966; 3: 185–98.
68. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34: 216–22.
69. Daniel PM, Prichard MM, Treip CS. Traumatic infarction of the anterior lobe of the pituitary gland. Lancet 1959; 2: 927–31.
70. Kornblum RN, Fisher RS. Pituitary lesions in craniocerebral injuries. Arch Path Lab Med 1969; 88: 242–8.
71. Popovic V, Pekic S, Pavlovic D, et al. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest 2004; 27: 1048–54.
72. Aimaretti G, Ambrosio MR, Benvenga S, et al. Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). Growth Horm IGF Res 2004; 14: S114–17.
73. Kelly DF, Gonzalo IT, Cohan P, et al. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg 2000; 93: 743–52.
74. Benvenga S, Campenni A, Ruggeri RM, et al. Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 2000; 85: 1353–61.
75. Casanueva FF, Leal A, Koltowska-Haggstrom M, et al. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: a KIMS-based study. Arch Phys Med Rehabil 2005; 86: 463–8.
76. Agha A, Phillips J, O'Kelly P, et al. The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. Am J Med 2005; 118: 1416.
77. Agha A, Thornton E, O'Kelly P, et al. Posterior pituitary dysfunction after traumatic brain injury. J Clin Endocrinol Metab 2004; 89: 5987–92.
78. Bavisetty S, McArthur DL, Dusick JR, et al. Chronic hypopituitarism after traumatic brain injury: risk assessment and relationship to outcome. Neurosurgery 2008; 62: 1080–93.
79. Park KD, Kim DY, Lee JK, et al. Anterior pituitary dysfunction in moderate-to-severe chronic traumatic brain injury patients and the influence on functional outcome. Brain Inj 2010; 24: 1330–5.
80. High WM, Briones-Galang M, Clark JA, et al. Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma 2010; 27: 1565–75.
81. Springer J, Chollet A. A traumatic car crash. Lancet 2001; 357: 1848.
82. Ghigo E, Masel B, Aimaretti G, et al. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj 2005; 19: 711–24.
83. Katz RT, Brander V, Sahgal V. Updates on the diagnosis and management of posttraumatic hydrocephalus. Am J Phys Med Rehabil 1989; 68: 91–6.
84. Zasler NKD, Zafonte R. Brain Injury Medicine: Principles and Practice. New York, NY: Demos, 2007.
85. Aminoff MGD, Simon R. Clinical Neurology. New York, NY: McGraw-Hill, 2005.
86. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996; 71: 576–86.
87. Yablon SA. Posttraumatic seizures. Arch Phys Med Rehabil 1993; 74: 983–1001.
88. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery 1990; 27: 1–11.
89. Payan H, Toga M, Berard-Badier M. The pathology of post-traumatic epilepsies. Epilepsia 1970; 11: 81–94.
90. Agrawal A, Timothy J, Pandit L, et al. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg 2006; 108: 433–9.
91. Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia 2003; 44: 18–20.
92. Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998; 51: 1256–62.
93. Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology 1980; 30: 683–9.
94. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001; 42: 515–24.
95. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003; 60: 10–16.
96. Dikmen SS, Temkin NR, Miller B, et al. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991; 265: 1271–7.
97. Perna R. Brain injury: benzodiazepines, antipsychotics, and functional recovery. J Head Trauma Rehabil 2006; 21: 82–4.
98. Young RR. Spasticity: a review. Neurology 1994; 44: S12–20.
99. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–7.
100. Ansari NN, Naghdi S, Hasson S, et al. The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj 2008; 22: 1007–12.
101. Rekand T. Clinical assessment and management of spasticity: a review. Acta Neurol Scand 2010; 190: 62–6.
102. Tan J. Practice Manual of Physical Medicine and Rehabilitation. St Louis, MO: Mosby, 1998.
103. Kaplan FS, Glaser DL, Hebela N, et al. Heterotopic ossification. J Am Acad Orthop Surg 2004; 12: 116–25.
104. Watanabe TKSM. Common medical complications of traumatic brain injury. Phys Med Rehabil 2001; 15: 283–99.
105. Van den Bossche L, Van der Straeten G. Heterotopic ossification: a review. J Rehabil Med 2005; 37: 129–36.
106. Blackman JA, Patrick PD, Buck ML, et al. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 2004; 61: 321–8.
107. Baguley IJ, Cameron ID, Green AM, et al. Pharmacological management of dysautonomia following traumatic brain injury. Brain Inj 2004; 18: 409–17.
108. Bullard DE. Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol 1987; 21: 609–11.
109. Wang VY, Manley G. Recognition of paroxysmal autonomic instability with dystonia (PAID) in a patient with traumatic brain injury. J Trauma 2008; 64: 500–2.
110. McAllister TW. Neurobehavioral sequelae of traumatic brain injury: evaluation and management. World Psychiatry 2008; 7: 3–10.
111. Tsaousides T, Gordon WA. Cognitive rehabilitation following traumatic brain injury: assessment to treatment. Mt Sinai J Med 2009; 76: 173–81.
112. McCrea M, Guskiewicz KM, Marshall SW, et al. Acute effects and recovery time following concussion in collegiate football players: the NCAA concussion study. JAMA 2003; 290: 2556–63.
113. Ruttan L, Martin K, Liu A, et al. Long-term cognitive outcome in moderate to severe traumatic brain injury: a meta-analysis examining timed and untimed tests at 1 and 4.5 or more years after injury. Arch Phys Med Rehabil 2008; 89: S69–76.
114. Sandel ME, Mysiw WJ. The agitated brain injured patient. Part 1: Definitions, differential diagnosis, and assessment. Arch Phys Med Rehabil 1996; 77: 617–23.
115. Nott MT, Chapparo C, Baguley IJ. Agitation following traumatic brain injury: an Australian sample. Brain Inj 2006; 20: 1175–82.
116. Rogers JM, Read CA. Psychiatric comorbidity following traumatic brain injury. Brain Inj 2007; 21: 1321–33.
117. Whelan-Goodinson R, Ponsford J, Johnston L, et al. Psychiatric disorders following traumatic brain injury: their nature and frequency. J Head Trauma Rehabil 2009; 24: 324–32.
118. Simpson G, Tate R. Suicidality in people surviving a traumatic brain injury: prevalence, risk factors and implications for clinical management. Brain Inj 2007; 21: 1335–51.
119. King NS. PTSD and traumatic brain injury: folklore and fact? Brain Inj 2008; 22: 1–5.
120. van Reekum R, Cohen T, Wong J. Can traumatic brain injury cause psychiatric disorders? J Neuropsychiatry Clin Neurosci 2000; 12: 316–27.
121. Minderhoud JM, Boelens ME, Huizenga J, et al. Treatment of minor head injuries. Clin Neurol Neurosurg 1980; 82: 127–40.
122. Baandrup L, Jensen R. Chronic post-traumatic headache–a clinical analysis in relation to the International Headache Classification, 2nd edition. Cephalalgia 2005; 25: 132–8.
123. Evans RW. Post-traumatic headaches. Neurol Clin 2004; 22: 237–49.
124. Packard RC. Epidemiology and pathogenesis of posttraumatic headache. J Head Trauma Rehabil 1999; 14: 9–21.
125. Bushnik T, Englander J, Wright J. The experience of fatigue in the first 2 years after moderate-to-severe traumatic brain injury: a preliminary report. J Head Trauma Rehabil 2008; 23: 17–24.
126. Ouellet MC, Savard J, Morin CM. Insomnia following traumatic brain injury: a review. Neurorehabil Neural Repair 2004; 18: 187–98.
127. Chen H, Epstein J, Stern E. Neural plasticity after acquired brain injury: evidence from functional neuroimaging. PM R 2010; 2: S306–12.
128. Weiller C, Chollet F, Friston KJ, et al. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992; 31: 463–72.
129. Werring DJ, Clark CA, Barker GJ, et al. The structural and functional mechanisms of motor recovery: complementary use of diffusion tensor and functional magnetic resonance imaging in a traumatic injury of the internal capsule. J Neurol Neurosurg Psychiatry 1998; 65: 863–9.
130. Nakamura T, Hillary FG, Biswal BB. Resting network plasticity following brain injury. PloS One 2009; 4: e8220.
131. Ween JE. Functional imaging of stroke recovery: an ecological review from a neural network perspective with an emphasis on motor systems. J Neuroimaging 2008; 18: 227–36.
132. Swaine BR, Sullivan SJ. Longitudinal profile of early motor recovery following severe traumatic brain injury. Brain Inj 1996; 10: 347–66.
133. Page S, Levine P. Forced use after TBI: promoting plasticity and function through practice. Brain Inj 2003; 17: 675–84.
134. Page SJ, Yablon S. Plasticity in TBI: concepts and applications. Brain Inj 2003; 17: 639–41.